PHARMACEUTICAL COMPOSITION； USE OF AT LEAST ONE NON-IONIC CELLULOSE ETHER； METHOD FOR PREPARING A PHARMACEUTICAL COMPOSITION； METHOD FOR TREATING AND / OR PREVENTING A CLIMATE CLIMATE； USE OF A PHARMACEUTICAL COMPOSITION； AND KIT
Pharmaceutical composition The present invention relates to an innovative pharmaceutical composition comprising oxytocin and / or one or more fragments and / or variants thereof and at least one nonionic cellulose ether as hydroxypropyl methylcellulose. that said pharmaceutical composition has a low ph. The present pharmaceutical composition has been shown to provide an exceptionally suitable environment for oxytocin as the stability of the oxytocin has increased significantly compared to prior compositions with such a molecule. The pharmaceutical composition according to the invention may be used for medical purposes as in the treatment of climatic disorders.composição farmacêutica a presente invenção refere-se a urna composição farmacêutica inovadora que compreende oci tocina e/ou urn ou mais fragrnento(s) e/ou variante(s) dos mesmos e pelo menos urn éter de celulose não iônico, corno hidroxipropilrnetilcelulose, sendo que a dita composição farmacêutica tern urn ph baixo. a presente composição farmacêutica demonstrou fornecer urn ambiente excepcionalmente adequado para ocitocina, conforme a estabilidade da mesma aumentou significativamente em comparação às composições anteriores corn essa molécula. a composição f arrnacêutica de acordo corn a invenção pode ser usada para fins medicinais, corno no tratamento de distúrbios climatéricos.
